Multicenter Observation on the Use of Biosimilar Epoetin alfa – A Non-interventional Trial in Patients with Chronic Kidney Disease Stage 5 on Change of Treatment Targets over Time

Trial Profile

Multicenter Observation on the Use of Biosimilar Epoetin alfa – A Non-interventional Trial in Patients with Chronic Kidney Disease Stage 5 on Change of Treatment Targets over Time

Recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Sep 2016

At a glance

  • Drugs Epoetin alfa (Primary)
  • Indications Renal failure
  • Focus Therapeutic Use
  • Acronyms MONITOR-HD
  • Sponsors HEXAL
  • Most Recent Events

    • 12 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top